risperidone has been researched along with Briquet Syndrome in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qureshi, NA | 1 |
| Al-Habeeb, TA | 1 |
| Al-Ghamdy, YS | 1 |
| Mercan, S | 1 |
| Altunay, IK | 1 |
| Taskintuna, N | 1 |
| Ogutcen, O | 1 |
| Kayaoğlu, S | 1 |
2 other studies available for risperidone and Briquet Syndrome
| Article | Year |
|---|---|
Making psychiatric sense of sand: a case of delusional disorder in Saudi Arabia.
Topics: Aged; Arabs; Culture; Delusions; Female; Follow-Up Studies; Humans; Personality Assessment; Pruritus | 2004 |
Atypical antipsychotic drugs in the treatment of delusional parasitosis.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studi | 2007 |